Florida / New York / No Carolina
Ph: 561.316.3330

IQAir Introduces New XE Smart Air Purifiers

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • For the North American market, the enhanced features of the XE air purifiers are incorporated into four of IQAir’s popular air purifiers and are now available on iqair.

IQAir, a Swiss air quality technology company, launches their new XE air purifiers, the next generation of their best-selling high-performance air purifiers, in North America.

IQAir XE air purifiers feature a redesigned fan system that is up to three times more energy efficient than previous models. With Wi-Fi smart app integration, the air purifiers can be remotely controlled and fully integrated with IQAir’s AirVisual air quality app and platform. The XEs also include three smart modes, allowing for sensor-based operation and prompting automatic adjustment of the air purifier performance based on measured air quality.

Designed and made in Switzerland, the XE line also includes an advanced particle sensor that measures harmful fine particulate pollutants (PM2.5), for real-time insight of indoor air. PM2.5 includes a wide range of pollutants, including smoke, dust, pollen, mold spores, house dust mites, and pet allergens. The HealthPro XE utilizes IQAir’s patented HyperHEPA filtration, which captures over 99.5% of harmful ultrafine pollution particles and biological contaminants down to 0.003 microns in size. This includes particulate matter equal in size of bacteria and viruses such as those that cause COVID-19, the flu, and even the common cold.

Frank Hammes, Global CEO, IQAir.

“The XE line pairs the newest air quality monitoring technology with our award-winning, ultra efficient filtration. Built-in air quality sensors allow the system to automatically adjust filtration according to indoor air quality. This saves energy, extends filter life, and fully automates the removal of even the smallest particles from the air.”

For the North American market, the enhanced features of the XE air purifiers are incorporated into four of IQAir’s popular air purifiers and are now available on iqair.com/us/:

  • HealthPro Plus XE is priced at $1,199
  • HealthPro Compact XE is priced at $1,099
  • GC MultiGas XE is priced at $1,599
  • GCX MultiGas XE is priced at $2,499
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

VitaFlow Liberty ™ Granted EU CE-MDR Mark

Jeff Lindstrom, President of CardioFlow, stated, "The certification of VitaFlow Liberty by the CE regulatory body under MDR, is a testament to CardioFlow's world-class R&D, quality, and clinical capabilities. This recognition will expedite the global clinical adoption of the VitaFlowTM series along with other innovative products, advancing CardioFlow's globalization strategy. This achievement also positions us to make a more substantial contributions to developments in the field of heart valve interventions, ultimately benefiting patients across the globe."

Inspira Receives 1st Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

Inspira reports the first units are expected to be shipped in Q4 2024. The Purchase Order follows the recent FDA Clearance of the INSPIRA™ ART100.

Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility

The purchase order includes deliveries for both the 10mL and 50mL specialty copolymer prefillable syringes that will be manufactured at the West Columbia site being acquired from Nephron. This assurance of supply is expected to support the planned expansion of the 503b operations at the Nephron site. The new copolymer syringe technology reflects the pharmaceutical and healthcare industry’s trend toward transitioning injectable drug therapies into innovative polymer prefillable syringes and away from the older glass and standard plastic syringes reports Sharps Technology.

By using this website you agree to accept Medical Device News Magazine Privacy Policy